Variant report
Variant | nsv517176 |
---|---|
Chromosome Location | chr7:19464027-19468258 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2192473 | chr7:19464027-19464028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572898651 | chr7:19464032-19464033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539951600 | chr7:19464042-19464043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77205454 | chr7:19464048-19464049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573543926 | chr7:19464076-19464077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6966182 | chr7:19464080-19464081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
7 | rs562466472 | chr7:19464088-19464089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533024810 | chr7:19464090-19464091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544814823 | chr7:19464165-19464166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187979310 | chr7:19464243-19464244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143947818 | chr7:19464256-19464257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192603092 | chr7:19464309-19464310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6948616 | chr7:19464344-19464345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550959910 | chr7:19464379-19464380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569579449 | chr7:19464439-19464440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551686604 | chr7:19464441-19464442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146360868 | chr7:19464470-19464471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558434974 | chr7:19464481-19464482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566941029 | chr7:19464482-19464483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75453586 | chr7:19464522-19464523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371636131 | chr7:19464596-19464597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370967870 | chr7:19464606-19464607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540740801 | chr7:19464635-19464636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200089661 | chr7:19464674-19464675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184499396 | chr7:19464723-19464724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543823788 | chr7:19464752-19464753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555701291 | chr7:19464793-19464794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150036356 | chr7:19464807-19464808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544900325 | chr7:19464817-19464818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190423137 | chr7:19464836-19464837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192541899 | chr7:19464845-19464846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184925134 | chr7:19464870-19464871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562717315 | chr7:19464876-19464877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562056107 | chr7:19464900-19464901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374034413 | chr7:19464948-19464949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77589343 | chr7:19464993-19464994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541957112 | chr7:19465046-19465047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73260262 | chr7:19465118-19465119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533706865 | chr7:19465136-19465137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562204612 | chr7:19465145-19465146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145497323 | chr7:19465156-19465157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567078845 | chr7:19465163-19465164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534154689 | chr7:19465227-19465228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549523586 | chr7:19465238-19465239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148854470 | chr7:19465309-19465310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537502905 | chr7:19465320-19465321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555788950 | chr7:19465330-19465331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548088937 | chr7:19465362-19465363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567934307 | chr7:19465393-19465394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373430062 | chr7:19465411-19465412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:19462200-19467200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr7:19462200-19467400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr7:19462200-19467400 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr7:19462200-19467400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr7:19462400-19467200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr7:19462800-19464400 | Enhancers | Adipose Nuclei | Adipose |
7 | chr7:19463400-19465200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr7:19463400-19465400 | Enhancers | Fetal Stomach | stomach |
9 | chr7:19463800-19465400 | Enhancers | Fetal Heart | heart |
10 | chr7:19464000-19464400 | Enhancers | Fetal Lung | lung |
11 | chr7:19467000-19468000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
12 | chr7:19467200-19468000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr7:19467200-19468000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr7:19467200-19468200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr7:19467400-19467800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr7:19467400-19468000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr7:19467400-19468000 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr7:19467400-19468000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr7:19467400-19468000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
20 | chr7:19467400-19468200 | Enhancers | H9 Cell Line | embryonic stem cell |
21 | chr7:19467600-19468000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |